Mobile Cardiac Outpatient Telemetry for Unexplained Syncope
Launched by CARILION CLINIC · Jul 14, 2023
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a device called the Philips mobile cardiac outpatient telemetry (MCOT) to see if it can help improve care for patients who experience unexplained fainting (syncope) or near fainting episodes. The goal is to find out if using this device can help doctors diagnose heart problems more quickly and provide better treatment. Patients aged 50 and older who come to the emergency department with these fainting issues may be eligible to participate. To qualify, they need to be willing to enroll in the study, speak English, and have a reliable way to receive follow-up phone calls.
If someone joins the study, they will be randomly assigned to either receive the MCOT device or to get standard care. The device will be placed on them when they leave the hospital, and they will receive instructions on how to use it. Participants will have follow-up phone calls from the research team at 14 and 30 days after enrollment to check in on their health. This trial is not yet recruiting participants, but it aims to provide valuable information about how this technology can help patients with unexplained fainting.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • ED presentation for syncope or near syncope without identified cause of syncope during ED evaluation
- • Willingness to enroll in the trial
- • greater than or equal to 50 years of age
- • cell phone coverage at their primary residence
- • home or cell phone service for follow up calls
- • ability to answer questionnaires without assistance
- • English language speaker
- Exclusion Criteria:
- • unwillingness to participate in the study
- • unable to consent on their own
- • seizure as presumptive cause of loss of consciousness
- • stroke, or transient ischemic attack as presumptive loss of consciousness
- • loss of consciousness following head trauma
- • confusion from baseline mental status (altered mental status)
- • intoxication (alcohol or other drugs)
- • medical or electrical intervention required to restore consciousness
- • hypoglycemia as presumptive cause of loss of consciousness
- • inability to provide follow up via telephone (phone that is not regularly in service)
- • lack of permanent address (e.g. not a homeless shelter, half-way house, psychiatric treatment facility, or correctional facility)
- • Lack of continuous cellular phone service with ATT, Verizon, or T-Mobile for MCOT relay
- • known pregnancy
- • Illiteracy
About Carilion Clinic
Carilion Clinic is a comprehensive healthcare organization based in Virginia, dedicated to providing exceptional patient care, advancing medical research, and enhancing community health. As a leading clinical trial sponsor, Carilion Clinic leverages its extensive network of healthcare professionals and cutting-edge facilities to conduct innovative research across a variety of therapeutic areas. Committed to improving patient outcomes, Carilion Clinic collaborates with academic institutions and industry partners to facilitate clinical trials that adhere to the highest ethical standards and regulatory guidelines, ultimately contributing to the advancement of medical science and the discovery of new treatment options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported